10-K Filing

Monte Rosa Therapeutics, Inc. CIK: 1826457 FY 2023

Filing Information

Form Type	10-K
Accession Number	`0000950170-24-031150`
Period End Date	20231231
Filing Date	20240314
Fiscal Year	2023
Fiscal Period	FY
XBRL Instance	glue-20231231_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 73 Income Statement 40 Cash Flow Statement 77 Stockholders Equity 23

Balance Sheet 73 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$54.91M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$128.10M	USD	Point-in-time
Marketable securities	`MarketableSecurities`	$207.91M	USD	Point-in-time
Marketable securities	`MarketableSecurities`	$104.31M	USD	Point-in-time
Other receivables	`OtherReceivables`	$7.66M	USD	Point-in-time
Other receivables	`OtherReceivables`	$505.00K	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$3.29M	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$4.44M	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Current restricted cash	`RestrictedCashCurrent`	-	USD	Point-in-time
Current restricted cash	`RestrictedCashCurrent`	$960.00K	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock, shares Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Total current assets	`AssetsCurrent`	$275.89M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$236.21M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$27.07M	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$33.80M	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$28.81M	USD	Point-in-time
Common stock, par or stated value per share	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$34.83M	USD	Point-in-time
Common stock, par or stated value per share	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	500.00M	shares	Point-in-time
Restricted cash, net of current	`RestrictedCashNoncurrent`	$4.58M	USD	Point-in-time
Restricted cash, net of current	`RestrictedCashNoncurrent`	$4.32M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	500.00M	shares	Point-in-time
Common stock, shares, issued	`CommonStockSharesIssued`	50.15M	shares	Point-in-time
Common stock, shares, issued	`CommonStockSharesIssued`	49.45M	shares	Point-in-time
Other long-term assets	`OtherAssetsNoncurrent`	$352.00K	USD	Point-in-time
Other long-term assets	`OtherAssetsNoncurrent`	$278.00K	USD	Point-in-time
Total assets	`Assets`	$303.75M	USD	Point-in-time
Common stock shares outstanding	`CommonStockSharesOutstanding`	49.32M	shares	Point-in-time
Total assets	`Assets`	$342.39M	USD	Point-in-time
Common stock shares outstanding	`CommonStockSharesOutstanding`	50.14M	shares	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$11.15M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$7.86M	USD	Point-in-time
Accrued expenses and other current liabilities	`AccountsPayableAndOtherAccruedLiabilitiesCurrent`	$14.58M	USD	Point-in-time
Accrued expenses and other current liabilities	`AccountsPayableAndOtherAccruedLiabilitiesCurrent`	$14.60M	USD	Point-in-time
Current deferred revenue	`DeferredRevenueCurrent`	-	USD	Point-in-time
Current deferred revenue	`DeferredRevenueCurrent`	$17.68M	USD	Point-in-time
Current portion of operating lease liability	`OperatingLeaseLiabilityCurrent`	$3.16M	USD	Point-in-time
Current portion of operating lease liability	`OperatingLeaseLiabilityCurrent`	$3.13M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$25.57M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$46.59M	USD	Point-in-time
Deferred revenue, net of current	`DeferredRevenue`	$32.32M	USD	Point-in-time
Deferred revenue, net of current	`DeferredRevenue`	-	USD	Point-in-time
Defined benefit plan liability	`DefinedBenefitPensionPlanLiabilitiesNoncurrent`	$2.71M	USD	Point-in-time
Defined benefit plan liability	`DefinedBenefitPensionPlanLiabilitiesNoncurrent`	$1.53M	USD	Point-in-time
Operating lease liability	`OperatingLeaseLiabilityNoncurrent`	$42.88M	USD	Point-in-time
Operating lease liability	`OperatingLeaseLiabilityNoncurrent`	$43.87M	USD	Point-in-time
Total liabilities	`Liabilities`	$124.50M	USD	Point-in-time
Total liabilities	`Liabilities`	$70.98M	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, $0.0001 par value, 10,000,000 shares authorized, no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.0001 par value, 10,000,000 shares authorized, no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.0001 par value; 500,000,000 shares authorized, 50,154,929 shares issued and 50,140,233 shares outstanding as of December 31, 2023; and 500,000,000 shares authorized, 49,445,802 shares issued and 49,323,531 shares outstanding as of December 31, 2022	`CommonStockValue`	$5.00K	USD	Point-in-time
Common stock, $0.0001 par value; 500,000,000 shares authorized, 50,154,929 shares issued and 50,140,233 shares outstanding as of December 31, 2023; and 500,000,000 shares authorized, 49,445,802 shares issued and 49,323,531 shares outstanding as of December 31, 2022	`CommonStockValue`	$5.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$503.70M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$547.86M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-1.75M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-2.72M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-230.54M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-365.89M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$347.51M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$179.25M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$271.41M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$342.39M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$303.75M	USD	Point-in-time

Income Statement 40 line items

Line Item	Tag	Value	Unit	Period
Research and development	`ResearchAndDevelopmentExpense`	$85.06M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$111.27M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$32.04M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$27.32M	USD	Annual
Total operating expenses	`OperatingExpenses`	$112.38M	USD	Annual
Total operating expenses	`OperatingExpenses`	$143.31M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-112.38M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-143.31M	USD	Annual
Interest income	`InterestIncomeExpenseNonoperatingNet`	$3.76M	USD	Annual
Interest income	`InterestIncomeExpenseNonoperatingNet`	$9.33M	USD	Annual
Foreign currency exchange gain (loss), net	`ForeignCurrencyTransactionGainLossBeforeTax`	$-930.00K	USD	Annual
Foreign currency exchange gain (loss), net	`ForeignCurrencyTransactionGainLossBeforeTax`	$10.00K	USD	Annual
Gain on disposal of fixed assets	`GainLossOnDispositionOfAssets1`	$24.00K	USD	Annual
Gain on disposal of fixed assets	`GainLossOnDispositionOfAssets1`	$109.00K	USD	Annual
Loss on sale of marketable securities	`MarketableSecuritiesGainLoss`	-	USD	Annual
Loss on sale of marketable securities	`MarketableSecuritiesGainLoss`	$-131.00K	USD	Annual
Total other income	`NonoperatingIncomeExpense`	$8.30M	USD	Annual
Total other income	`NonoperatingIncomeExpense`	$3.88M	USD	Annual
Net loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-135.01M	USD	Annual
Net loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-108.50M	USD	Annual
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	Annual
Provision for income taxes	`IncomeTaxExpenseBenefit`	$338.00K	USD	Annual
Net loss	`NetIncomeLoss`	$-108.50M	USD	Annual
Net loss	`NetIncomeLoss`	$-135.35M	USD	Annual
Net loss per share attributable to common stockholders - basic	`IncomeLossFromContinuingOperationsPerBasicShare`	$-2.63	USD	Annual
Net loss per share attributable to common stockholders - basic	`IncomeLossFromContinuingOperationsPerBasicShare`	$-2.30	USD	Annual
Net loss per share attributable to common stockholders - diluted	`IncomeLossFromContinuingOperationsPerDilutedShare`	$-2.30	USD	Annual
Net loss per share attributable to common stockholders - diluted	`IncomeLossFromContinuingOperationsPerDilutedShare`	$-2.63	USD	Annual
Weighted-average number of shares outstanding used in computing net loss per common share - basic	`WeightedAverageNumberOfSharesOutstandingBasic`	51.40M	shares	Annual
Weighted-average number of shares outstanding used in computing net loss per common share - basic	`WeightedAverageNumberOfSharesOutstandingBasic`	47.23M	shares	Annual
Weighted-average number of shares outstanding used in computing net loss per common share - diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	47.23M	shares	Annual
Weighted-average number of shares outstanding used in computing net loss per common share - diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	51.40M	shares	Annual
Net Income (Loss)	`NetIncomeLoss`	$-108.50M	USD	Annual
Net Income (Loss)	`NetIncomeLoss`	$-135.35M	USD	Annual
Provision for pension benefit obligation	`ProvisionForPensionBenefitObligation`	$-1.37M	USD	Annual
Provision for pension benefit obligation	`ProvisionForPensionBenefitObligation`	$718.00K	USD	Annual
Unrealized gain (loss) on available-for-sale securities	`DebtSecuritiesAvailableForSaleRealizedLoss`	$449.00K	USD	Annual
Unrealized gain (loss) on available-for-sale securities	`DebtSecuritiesAvailableForSaleRealizedLoss`	$-397.00K	USD	Annual
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-108.23M	USD	Annual
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-136.32M	USD	Annual

Cash Flow Statement 77 line items

Line Item	Tag	Value	Unit	Period
Issuance of common stock, net of underwriting discount	`NetOfUnderwritingDiscountOnIssuanceOfCommonStock`	$620.00K	USD	Annual
Issuance of common stock, net of underwriting discount	`NetOfUnderwritingDiscountOnIssuanceOfCommonStock`	$620.00K	USD	Annual
Net loss	`ProfitLoss`	$-135.35M	USD	Annual
Net loss	`ProfitLoss`	$-108.50M	USD	Annual
Stock-based compensation expense	`ShareBasedCompensation`	$16.67M	USD	Annual
Stock-based compensation expense	`ShareBasedCompensation`	$11.66M	USD	Annual
Depreciation	`Depreciation`	$6.22M	USD	Annual
Depreciation	`Depreciation`	$3.75M	USD	Annual
Noncash lease expense	`NoncashLeaseExpense`	-	USD	Annual
Noncash lease expense	`NoncashLeaseExpense`	$4.81M	USD	Annual
Net accretion of discounts/premiums on marketable securities	`AccretionOfDiscountsPremiumsOnMarketableSecuritiesNet`	$-3.91M	USD	Annual
Net accretion of discounts/premiums on marketable securities	`AccretionOfDiscountsPremiumsOnMarketableSecuritiesNet`	$-1.95M	USD	Annual
Loss on sale of marketable securities	`MarketableSecuritiesRealizedGainLoss`	$-131.00K	USD	Annual
Loss on sale of marketable securities	`MarketableSecuritiesRealizedGainLoss`	-	USD	Annual
Gain on disposal of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	$24.00K	USD	Annual
Gain on disposal of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	$109.00K	USD	Annual
Other receivables	`IncreaseDecreaseInOtherReceivables`	$187.00K	USD	Annual
Other receivables	`IncreaseDecreaseInOtherReceivables`	$-1.90M	USD	Annual
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-1.08M	USD	Annual
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$2.13M	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$5.76M	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-744.00K	USD	Annual
Accrued expenses and other current liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$3.56M	USD	Annual
Accrued expenses and other current liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$1.03M	USD	Annual
Defined benefit plan liability	`DefinedBenefitPlanOtherChanges`	$-74.00K	USD	Annual
Defined benefit plan liability	`DefinedBenefitPlanOtherChanges`	$188.00K	USD	Annual
Right-of-use assets and operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$-181.00K	USD	Annual
Right-of-use assets and operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$10.37M	USD	Annual
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$50.00M	USD	Annual
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	-	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-92.47M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-43.80M	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$12.91M	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$19.04M	USD	Annual
Proceeds from sale of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$109.00K	USD	Annual
Proceeds from sale of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$62.00K	USD	Annual
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$384.42M	USD	Annual
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$103.15M	USD	Annual
Proceeds from sale of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$45.63M	USD	Annual
Proceeds from sale of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	-	USD	Annual
Proceeds from maturities of marketable securities	`Proceedsfrommaturityofmarketablesecurities`	$178.00M	USD	Annual
Proceeds from maturities of marketable securities	`Proceedsfrommaturityofmarketablesecurities`	$165.30M	USD	Annual
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-219.22M	USD	Annual
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$88.80M	USD	Annual
Proceeds from issuance of common stock, net of underwriting discount of $620	`ProceedsFromIssuanceOfCommonStock`	$20.05M	USD	Annual
Proceeds from issuance of common stock, net of underwriting discount of $620	`ProceedsFromIssuanceOfCommonStock`	-	USD	Annual
Proceeds from issuance of pre-funded warrants	`ProceedsFromIssuanceOfWarrants`	$25.00M	USD	Annual
Proceeds from issuance of pre-funded warrants	`ProceedsFromIssuanceOfWarrants`	-	USD	Annual
Proceeds from exercise of employee stock options	`ProceedsFromStockOptionsExercised`	$2.03M	USD	Annual
Proceeds from exercise of employee stock options	`ProceedsFromStockOptionsExercised`	$439.00K	USD	Annual
Proceeds from employee stock purchase plan	`ProceedsFromIssuanceOfCommonStockDividendReinvestmentPlan`	$336.00K	USD	Annual
Proceeds from employee stock purchase plan	`ProceedsFromIssuanceOfCommonStockDividendReinvestmentPlan`	$578.00K	USD	Annual
Payment of common stock issuance costs	`PaymentOfFinancingAndStockIssuanceCosts`	$364.00K	USD	Annual
Payment of common stock issuance costs	`PaymentOfFinancingAndStockIssuanceCosts`	-	USD	Annual
Payment of pre-funded warrant issuance costs	`PaymentToPreFundedWarrantIssuanceCosts`	-	USD	Annual
Payment of pre-funded warrant issuance costs	`PaymentToPreFundedWarrantIssuanceCosts`	$116.00K	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$20.47M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$27.49M	USD	Annual
Net decrease in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$72.49M	USD	Annual
Net decrease in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-291.22M	USD	Annual
Cash, cash equivalents and restricted cashbeginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$132.68M	USD	Point-in-time
Cash, cash equivalents and restricted cashbeginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$351.41M	USD	Point-in-time
Cash, cash equivalents and restricted cashbeginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$60.19M	USD	Point-in-time
Cash, cash equivalents and restricted cashend of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$132.68M	USD	Point-in-time
Cash, cash equivalents and restricted cashend of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$351.41M	USD	Point-in-time
Cash, cash equivalents and restricted cashend of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$60.19M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$54.91M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$128.10M	USD	Point-in-time
Restricted cash	`RestrictedCash`	$4.58M	USD	Point-in-time
Restricted cash	`RestrictedCash`	$5.28M	USD	Point-in-time
Total cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$132.68M	USD	Point-in-time
Total cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$351.41M	USD	Point-in-time
Total cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$60.19M	USD	Point-in-time
Reduction of right-of-use assets for lease incentives receivable	`ReductionOfRightOfUseAssetsForLeaseIncentivesReceivable`	$7.47M	USD	Annual
Reduction of right-of-use assets for lease incentives receivable	`ReductionOfRightOfUseAssetsForLeaseIncentivesReceivable`	$5.25M	USD	Annual
Purchases of property and equipment in accounts payable and accrued expenses	`CapitalExpendituresIncurredButNotYetPaid`	$6.24M	USD	Annual
Purchases of property and equipment in accounts payable and accrued expenses	`CapitalExpendituresIncurredButNotYetPaid`	$237.00K	USD	Annual

Stockholders Equity 23 line items

Line Item	Tag	Value	Unit	Period
Net issuance costs	`PaymentsOfStockIssuanceCosts`	$984.00K	USD	Annual
Net issuance costs	`PaymentsOfStockIssuanceCosts`	$116.00K	USD	Annual
Balance, amount	`StockholdersEquity`	$347.51M	USD	Point-in-time
Balance, amount	`StockholdersEquity`	$179.25M	USD	Point-in-time
Balance, amount	`StockholdersEquity`	$271.41M	USD	Point-in-time
Exercise of common stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$439.00K	USD	Annual
Exercise of common stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$2.03M	USD	Annual
Exercise of common stock options, shares	`StockIssuedDuringPeriodSharesStockOptionsExercised`	561,905.00	shares	Annual
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$11.66M	USD	Annual
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$16.67M	USD	Annual
Provision for pension benefit obligation	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	$718.00K	USD	Annual
Provision for pension benefit obligation	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	$-1.37M	USD	Annual
Issuance of common stock, net of issuance costs	`IssuanceOfCommonStockNetOfIssuanceCosts`	$19.69M	USD	Annual
Unrealized loss on available-for-sale securities	`AvailableForSaleDebtSecuritiesGrossUnrealizedLoss`	$449.00K	USD	Annual
Unrealized loss on available-for-sale securities	`AvailableForSaleDebtSecuritiesGrossUnrealizedLoss`	$397.00K	USD	Annual
Issuance of shares under employee stock purchase plan	`StockIssuedDuringPeriodValueEmployeeStockPurchasePlan`	$336.00K	USD	Annual
Issuance of shares under employee stock purchase plan	`StockIssuedDuringPeriodValueEmployeeStockPurchasePlan`	$578.00K	USD	Annual
Issuance of pre-funded warrant, net of issuance costs	`IssuanceOfPreFundedWarrantNetOfIssuanceCosts`	$24.88M	USD	Annual
Net Income (Loss)	`NetIncomeLoss`	$-108.50M	USD	Annual
Net Income (Loss)	`NetIncomeLoss`	$-135.35M	USD	Annual
Balance, amount	`StockholdersEquity`	$347.51M	USD	Point-in-time
Balance, amount	`StockholdersEquity`	$179.25M	USD	Point-in-time
Balance, amount	`StockholdersEquity`	$271.41M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.